{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:58:52Z","timestamp":1777395532630,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.cca.2021.10.031","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T20:03:13Z","timestamp":1635451393000},"page":"402-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["BVVLS2 overlooked for 3\u00a0years in a pediatric patient caused by novel compound heterozygous mutations in SLC52A2 gene"],"prefix":"10.1016","volume":"523","author":[{"given":"Ziqiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunbao","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1647-0547","authenticated-orcid":false,"given":"Xiaomei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cca.2021.10.031_b0005","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1093\/brain\/aws161","article-title":"Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease","volume":"135","author":"Johnson","year":"2012","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.cca.2021.10.031_b0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/brain\/awt315","article-title":"Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2","volume":"137","author":"Foley","year":"2014","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.cca.2021.10.031_b0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10545-016-9950-0","article-title":"Riboflavin transport and metabolism in humans","volume":"39","author":"Barile","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"11","key":"10.1016\/j.cca.2021.10.031_b0020","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1093\/brain\/awx231","article-title":"Clinical, pathological and functional characterization of riboflavin-responsive neuropathy","volume":"140","author":"Manole","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.cca.2021.10.031_b0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.spen.2017.03.001","article-title":"Genetic, Radiologic, and Clinical Variability in Brown-Vialetto-van Laere Syndrome","volume":"26","author":"Woodcock","year":"2018","journal-title":"Semin. Pediatr. Neurol."},{"issue":"6","key":"10.1016\/j.cca.2021.10.031_b0030","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10545-012-9513-y","article-title":"Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown-Vialetto-Van Laere syndrome","volume":"35","author":"Haack","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2021.10.031_b0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-0716-1286-6_4","article-title":"Functional Study of the Human Riboflavin Transporter 2 Using Proteoliposomes System","volume":"2280","author":"Console","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cca.2021.10.031_b0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-0716-1286-6_7","article-title":"Continuous and Discontinuous Approaches to Study FAD Synthesis and Degradation Catalyzed by Purified Recombinant FAD Synthase or Cellular Fractions","volume":"2280","author":"Leone","year":"2021","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.cca.2021.10.031_b0045","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40261-021-01038-1","article-title":"Riboflavin in Neurological Diseases: A Narrative Review","volume":"41","author":"Plantone","year":"2021","journal-title":"Clin. Drug Investig."},{"issue":"4","key":"10.1016\/j.cca.2021.10.031_b0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/0883073819893159","article-title":"The Clinical Journey of Patients with Riboflavin Transporter Deficiency Type 2","volume":"35","author":"Amir","year":"2020","journal-title":"J. Child. Neurol."},{"issue":"3","key":"10.1016\/j.cca.2021.10.031_b0055","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ajhg.2010.02.006","article-title":"Brown-Vialetto-Van Laere Syndrome, a Ponto-Bulbar Palsy with Deafness, Is Caused by Mutations in C20orf54","volume":"86","author":"Green","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.cca.2021.10.031_b0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10545-010-9242-z","article-title":"Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: A new inborn error of metabolism with potential treatment","volume":"34","author":"Bosch","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"11","key":"10.1016\/j.cca.2021.10.031_b0065","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1002\/ajmg.a.61851","article-title":"Hematologic presentation and the role of untargeted metabolomics analysis in monitoring treatment for riboflavin transporter deficiency","volume":"182","author":"Pillai","year":"2020","journal-title":"Am. J. Med. Genet. Part A"},{"issue":"4","key":"10.1016\/j.cca.2021.10.031_b0070","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jimd.12053","article-title":"An update on the genetics, clinical presentation, and pathomechanisms of human riboflavin transporter deficiency","volume":"42","author":"O\u2019Callaghan","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.cca.2021.10.031_b0075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1079\/BJN19930055","article-title":"A proposed intestinal mechanism for the effect of riboflavin deficiency on iron loss in the rat","volume":"69","author":"Powers","year":"1993","journal-title":"Br. J. Nutr."},{"issue":"1","key":"10.1016\/j.cca.2021.10.031_b0080","doi-asserted-by":"crossref","DOI":"10.1186\/s12881-019-0811-1","article-title":"A Chinese pedigree with Brown-Vialetto-Van Laere syndrome due to two novel mutations of SLC52A2 gene: Clinical course and response to riboflavin","volume":"20","author":"Shi","year":"2019","journal-title":"BMC Med. Genet."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121003752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121003752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:05:15Z","timestamp":1757862315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898121003752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":16,"alternative-id":["S0009898121003752"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2021.10.031","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BVVLS2 overlooked for 3\u00a0years in a pediatric patient caused by novel compound heterozygous mutations in SLC52A2 gene","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2021.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}